Results
eNauka >
Results >
OPTIMAL: a multinational phase III study of oral paclitaxel (DHP107) versus intravenous weekly paclitaxel in HER2-negative recurrent or metastatic breast cancer
| Title: | OPTIMAL: a multinational phase III study of oral paclitaxel (DHP107) versus intravenous weekly paclitaxel in HER2-negative recurrent or metastatic breast cancer | Authors  : | Xu, B; ...; Kostic, S; ...; Milenkovic, D; ...; (broj, koautora 21) | Issue Date: | 2026 | Publication: | ANNALS OF ONCOLOGY | ISSN: | 0923-7534 Annals of Oncology Search Idenfier |
Type: | Article | Collation: | vol. 37 br. 7 str. 936-945 | DOI: | 10.1016/j.annonc.2026.03.002 | WoS-ID: | 001809668200001 | Scopus-ID: | 2-s2.0-105036658896 | URI: | https://enauka.gov.rs/handle/123456789/1047358 | Project: | Daehwa Pharmaceutical Co., Ltd. Haihe Biopharma Co., Ltd. [2017-1216] |
Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | 21a+M21a+ |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.